Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ORASURE TECHNOLOGIES INC | Director | Common Stock | 112K | $915K | $8.19 | Aug 12, 2022 | Direct |
Larimar Therapeutics, Inc. | Chief Financial Officer | Common Stock | 144K | $537K | $3.73 | Jan 17, 2024 | Direct |
Larimar Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 188K | Jan 17, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LRMR | Larimar Therapeutics, Inc. | Jan 17, 2024 | 2 | $0 | 4 | Jan 19, 2024 | Chief Financial Officer |
LRMR | Larimar Therapeutics, Inc. | May 17, 2023 | 1 | $18.6K | 4 | May 18, 2023 | Chief Financial Officer |
LRMR | Larimar Therapeutics, Inc. | Jan 31, 2023 | 2 | $0 | 4 | Feb 2, 2023 | Chief Financial Officer |
LRMR | Larimar Therapeutics, Inc. | Sep 16, 2022 | 1 | $100K | 4 | Sep 19, 2022 | Chief Financial Officer |
OSUR | ORASURE TECHNOLOGIES INC | Aug 12, 2022 | 1 | $53.9K | 4 | Aug 16, 2022 | Director |
OSUR | ORASURE TECHNOLOGIES INC | May 16, 2022 | 2 | $112K | 4 | May 18, 2022 | Director |
LRMR | Larimar Therapeutics, Inc. | May 10, 2022 | 1 | $0 | 4 | May 12, 2022 | Chief Financial Officer |
LRMR | Larimar Therapeutics, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Chief Financial Officer |
OSUR | ORASURE TECHNOLOGIES INC | May 17, 2021 | 2 | $111K | 4 | May 19, 2021 | Director |